Abstract:Overexpression of P-glycoprotein leads to tumor multidrug resistance (MDR). HZ08, a novel tetrahydro-isoquinoline derivate, was discovered to inhibit the MDR in the cancer cell lines of MCF-7/ADM, K562/ADM and KBV in our previous studies. A rapid and sensitive ultra-performance liquid chromatography-tandem mass spectrometric method (UPLC-MS/MS) was developed and validated for determination of HZ08 in rat plasma and tissues after intravenous administration of HZ08 liposome injection at different doses. The analytes were extracted from plasma and tissues using protein precipitation by acetonitrile with clotrimazole as internal standard. The chromatographic separation was performed on a Thermo BDS HYPERSIL C18 column (100 mm x 4.6 mm, 2.4 mu m) at a flow rate of 0.7 ml/min using 0.2% ammonium acetate solution (containing 0.1% formic acid) and methanol as mobile phase. The total run time was 4 min. The tandem mass detection was applied with electrospray ionization in positive ion selected reaction monitoring mode. The ion transitions monitored were m/z 523.5 to 342.3 for HZ08 and 277.1 to 165.1 for the internal standard, respectively. The calibration curves obtained were linear in different matrices, and the lower limit of quantification (LLOQ) achieved was 1 ng/ml for rat plasma and 0.25 ng/ml for rat tissues, respectively. The RSDs for intra- and inter-day precision were less than 15%. Extraction recovery, matrix effect and stability were satisfactory in rat plasma and tissues. The developed method was successfully applied to a pharmacokinetic study of HZ08 liposome injection following intravenous administration of 1, 3, 10 mg/kg to Sprague-Dawley rats. The data profiles revealed that HZ08 had linear pharmacokinetic properties at the tested doses, and was rapidly distributed into the systemic circulation with wide distribution throughout the body followed by a rapid elimination phase. The major distribution tissues of HZ08 in rats were lung, spleen and liver. These results provided constructive contribution to support the clinical evaluation. (C) 2014 Elsevier B.V. All rights reserved.

A Rugged and Accurate Liquid Chromatography–tandem Mass Spectrometry Method for Quantitative Determination of BMS-790052 in Plasma

Development and Validation of an Lc-Ms/Ms Method for the Determination of Sb-505124 in Rat Plasma: Application to Pharmacokinetic Study

Determination of 4-Chloro-2-fluoro-3-methoxybenzeneboronic Acid in Rat Plasma by LC-MS/MS and Its Application in the Toxicokinetics Study

A simple and sensitive liquid chromatography triple quadrupole mass spectrometry method for the determination of XL092 in monkey plasma and its application to pharmacokinetic study

Development and Validation of a Highly Rapid and Sensitive LC–MS/MS Method for Determination of SZ-685C, an Investigational Marine Anticancer Agent, in Rat Plasma – Application to a Pharmacokinetic Study in Rats

Development and Validation of a Rapid LC-MS/MS Method for the Determination of JCC76, a Novel Antitumor Agent for Breast Cancer, in Rat Plasma and Its Application to a Pharmacokinetics Study.

Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry.

Sensitive Liquid Chromatography/tandem Mass Spectrometry Method for the Determination of Two Novel Highly Lipophilic Anticancer Drug Candidates in Rat Plasma and Tissues

Development and validation of an LC-MS/MS method for simultaneous quantification of eight drugs in plasma and brain: Application in a pharmacokinetic study in mice

LC-MS/MS method for the quantitation of a dual PI3K/BRD4 inhibitor SF2523 in mouse plasma: Application to plasma protein binding and metabolism studies

A sensitive LC-MS/MS method for simultaneous determination of cabozantinib and its metabolite cabozantinib N-oxide in rat plasma and its application in a pharmacokinetic study.

Development of a Rapid and Sensitive Liquid Chromatography/tandem Mass Spectrometry Method for the Determination of 1,2-[Bis(1,2-benzisoselenazolone-3(2h)-ketone)]-ethane (BBSKE), a Novel Anti-Cancer Agent in Rat Plasma.

Liquid Chromatography Tandem Mass Spectrometric Method for Quantification of Margetuximab in Rat Plasma and Application to a Pharmacokinetic Study

A UHPLC-MS/MS method for the quantification of JIB-04 in rat plasma: Development, validation and application to pharmacokinetics study

A High-Sensitivity Lc-Ms/Ms Method for the Determination of 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3, 3-Diphenylpropyl Ester Hydrochloride in Rat Plasma and Its Application to A Pharmacokinetics Study

A validated LC-MS/MS method for the simultaneous determination of BMS-791325, a hepatitis C virus NS5B RNA polymerase inhibitor, and its metabolite in plasma.

Development of a UPLC-MS-MS Method for Quantitative Determination of BYYT-25 in Rat Plasma and Its Application to a Pharmacokinetic Study

Development of an LC-MS/MS Method for Quantification of Kadsurenone in Rat Plasma and Its Application to a Pharmacokinetic Study.

A simple and sensitive ultra‐high performance liquid chromatography tandem mass spectrometry method for the quantitative analysis of VX‐548 in monkey plasma: Method validation and application to pharmacokinetic study

A Rapid and Sensitive UPLC–MS/MS Method for Determination of HZ08 in Rat Plasma and Tissues: Application to a Pharmacokinetic Study of Liposome Injections

Pharmacokinetic Study of 14-(3-methylbenzyl)matrine and 14-(4-methylbenzyl)matrine in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry.